Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04122014
Other study ID # H20190326180948
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 10, 2020
Est. completion date October 2020

Study information

Verified date January 2020
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effectiveness of a program of physiotherapy exercises to train the balance and dual task in adults patients with hemophilia


Description:

The objective of the study is to create an exercise program to improve the static and dynamic balance in hemophilic patient. In addition, the effect of the exercise program on dual task, functionality, proprioception, QoL, risk of falls and the kinesiophobia will be analyzed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 25
Est. completion date October 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Diagnosis of haemophilia A or B

- Willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations

- Approval by their hematologist to participate in the exercise program

- With hemostatic coverage supervised by your hematologist.

- Age between 18 and 60 years

- Informed consent signed.

Exclusion Criteria:

- Non adherence to instruction on proper exercise technique

- Surgical procedures performed 6 months prior to or during the exercise program

- A major bleeding episode that posed a risk or prevented exercise

- Need for major surgery

- Suffer from dizziness

- Withdrawal of informed consent

- Acquired hemophilia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Progressive balance training
Progressive balance training program
Normal daily activities
Usual daily activities

Locations

Country Name City State
Spain University of Valencia Valencia

Sponsors (1)

Lead Sponsor Collaborator
University of Valencia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of postural balance: amplitude of Center of Pressure (CoP) displacements Amplitude of CoP displacements will be assessed in millimeters using a computerized balance system. Higher displacements indicate worse balance. baseline and 3 months
Primary Change of postural balance: velocity of Center of Pressure (CoP) displacements Velocity of CoP displacements will be assessed in millimeters using a computerized balance system. Higher velocity indicate worse balance. baseline and 3 months
Primary Change of postural balance: sway area of Center of Pressure (CoP) displacements Sway area of CoP displacements will be assessed in mm^2 using a computerized balance system. Higher sway area indicate worse balance. baseline and 3 months
Primary Change of dual task balance: amplitude of Center of Pressure (CoP) displacements Amplitude of CoP displacements will be assessed in millimeters using a computerized balance system. Patient will perform a cognitive task (e.g. counting) while maintaining balance. Higher displacements indicate worse balance. baseline and 3 months
Primary Change of dual task balance: velocity of Center of Pressure (CoP) displacements Velocity of CoP displacements will be assessed in millimeters using a computerized balance system. Patient will perform a cognitive task (e.g. counting) while maintaining balance. Higher velocity indicate worse balance. baseline and 3 months
Primary Change of dual task balance: sway area of Center of Pressure (CoP) displacements Sway area of CoP displacements will be assessed in mm^2 using a computerized balance system. Patient will perform a cognitive task (e.g. counting) while maintaining balance. Higher sway area indicate worse balance. baseline and 3 months
Secondary Limits of Stability (LOS): success rate Evaluations will be done by NedSVE/IBV balance platform. Indices: Max Excursions (%), Directional Control (%), Success (%), LOS rate (%) will be recorded during forward, backward, right and left side movements. baseline and 3 months
Secondary Limits of Stability (LOS): time Evaluations will be done by NedSVE/IBV balance platform. Indices: Reaction Time (s), Confinement Time (s), will be recorded during forward, backward, right and left side movements. baseline and 3 months
Secondary The Berg Balance Scale Balance will be assessed with the Berg Balance Scale (BBS), a 14-item physical performance measure of static and dynamic balance found to be reliable. Scoring ranges from 0-56, with higher scores indicating better balance. A score of <46 identifies an individual at risk for falls after stroke. baseline and 3 months
Secondary Functional capacity: The Timed "Up & Go" test Timed "Up & Go" will be used to measure functional capacity. It is a simple test used to assess a person's mobility and requires both static and dynamic balance. Less time to complete the test in seconds implies better outcome. baseline and 3 months
Secondary Functional capacity: Sit-to-stand test Sit-to-stand test (3 repetitions) will be used to measure functional capacity. Less time to complete the test in seconds implies better outcome. baseline and 3 months
Secondary Functional capacity: 2-minutes walk test Evaluation of functional capacity during walking by using 2 minutes walk test. More distance covered in 2 minutes implies better outcome. baseline and 3 months
Secondary Haemophilia Activities List (HAL) The Haemophilia Activities List questionnaire measures the impact of hemophilia on self-perceived functional abilities in adults.
It contains 42 multiple choice questions in seven domains:
Lying/sitting/kneeling/standing (8 items) Functions of the legs (9 items) Functions of the arms (4 items) Use of transportation (3 items) Self-care (5 items) Household tasks (6 items) Leisure activities and sports (7 items) The most important outcomes are the overall sum score and three component scores relating to upper extremity activities, basic lower extremity activities, and complex lower extremity activities. The score is obtained using a Likert scale with 5 options: always=2, mostly=3, sometimes=4, rarely=5 and never=6 (complemented by the option "impossible=1" for those people who can not perform such activity). Subscales are summed, with a total score from 0- 252 and higher values represent a worse outcome (greater self-perceived difficulty in carrying out the activities).
baseline and 3 months
Secondary Functional Independence Scale for Hemophilia (FISH) Observed activity limitations will be measured with the Functional Independence Scale for Hemophilia (FISH) as part of the Activity Domain.
The scale studies 8 activities (eating and grooming, bathing, dressing, chair, squatting, walking, stairs and running), which are classified into the three groups (Self care, Transfers and Locomotion) and their score ranges from 1 - 4 (1 being the highest dependency and 4 being the greatest independence to perform the exercises). Subscales are summed, with a total score from 8-32 and higher values represent a better outcome.
The FISH has been validated for use in developing countries. It consists of observed activities of daily living that are scored for quality.
baseline and 3 months
Secondary Quality of Life related with health: questionnaire Measured by a Specific questionnaire for Quality of Life related with health evaluation for adults with haemophilia (A36Haemophilia-QoL), which explores 9 areas. Subscales and score range: Physical health: 0-32; Daily activities: 0-16; Joints: 0-12; Pain: 0-8; Treatment satisfaction: 0-8; Difficulties treatment: 0-16; Emotional functioning: 0-20; Mental health: 0-12; Social activity: 0-20. Subscales are summed, with a total score from 0-144 and higher values represent a better outcome (more Quality of Life perceived). baseline and 3 months
Secondary Kinesiophobia Kinesiophobia will be evaluated by Tampa Scale for Kinesiophobia (TSK-11SV) (Spanish adaptation. Gómez-Pérez, López-Martínez y Ruiz P., 2011). Scoring: Items are summed, with a total score from 11-44 and higher values represent a worse outcome (more pain interference in behavior). baseline and 3 months
Secondary Modified Falls Efficacy Scale (mFES) MFES is a 14-item questionnaire related to daily indoor and outdoor physical activities. It is a 10-point visual analog scale of confidence level in completing a particular activity (item) without falling, rated from 0 to 10, where 0 denotes not confident or sure at all, and 10 denotes completely confident or sure. The total score for the 14 items ranges from 0 to 140. baseline and 3 months
Secondary Joint health status Joint clinical evaluation of elbows, knees and ankles by using The Hemophilia Joint Health Score 2.1 (HJHS). The full score range goes from 0 to 124 points (0-20 points for each of the six joints evaluated, plus 4 points for the overall assessment of gait. 0 means no joint damage, whereas the higher the value, the higher the degree of arthropathy. baseline
See also
  Status Clinical Trial Phase
Completed NCT02229331 - Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.
Completed NCT02870114 - National Survey of People With Haemophilia in Portugal N/A
Recruiting NCT02197611 - Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. N/A
Unknown status NCT02582450 - Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia N/A
Completed NCT05138224 - Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia
Recruiting NCT03287999 - Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
Completed NCT02825667 - Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle N/A
Completed NCT03818529 - ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Completed NCT05108480 - Self-myofascial Release With Foam Roller in Patients With Hemophilic Knee Arthropathy N/A
Completed NCT02781233 - A Progressive Resistance Training Program in Patients With Haemophilia N/A
Active, not recruiting NCT02581735 - Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia N/A
Active, not recruiting NCT02512211 - Validation of Questionnaires HAL and HEP N/A
Not yet recruiting NCT01623960 - Quality of Life in Adult Patients With Severe Haemophilia in Turkey N/A
Recruiting NCT02191436 - Adherence to Treatment in Hemophilia N/A
Completed NCT03264014 - Combining Registry Data in Haemophilia: TARGET H N/A
Recruiting NCT02198430 - Multidisciplinary Evaluation of Patients With Hemophilia N/A
Not yet recruiting NCT06046235 - Virtual Evaluations of Joint Health Using Wearable Sensors in Persons With Haemophilia (VESPA)
Completed NCT03529474 - Psychology and Physiotherapy Approach of Chronic Pain in Patients With Hemophilia N/A
Completed NCT05425888 - Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy
Recruiting NCT03914209 - Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia